Market Overview:
The global non-invasive hemodynamic monitor market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cardiovascular diseases, technological advancements in hemodynamic monitoring devices, and rising demand for home-based and ambulatory care. By type, the continuously monitoring segment is expected to account for a larger share of the global market than the non-continuous monitoring segment during the forecast period. By application, hospitals are expected to account for a larger share of the global market than cath labs and home and ambulatory care during the forecast period. Geographically, North America is expected to dominate the global non-invasive hemodynamic monitor market duringthe forecast period followed by Europeand Asia Pacific.
Product Definition:
A non-invasive hemodynamic monitor is a device that measures heart function without having to insert any type of sensor into the body. This type of monitor is important because it allows clinicians to track a patient's heart function without having to perform invasive procedures.
Continuously:
Continuously is a non-invasive technique that measures the blood volume and oxygen perfusion rate in patients. It's major applications are in post-operative care, cardiopulmonary bypass surgery, intensive care unit (ICU) monitoring and for assessment of COVID patients. The product has been approved by the U.
Non-continuous:
Non-Continuous and it's usage in Non-invasive Hemodynamic Monitor market is used to measure the flow of blood or any other liquids that are not continuous. It is also known as intermittent pressure monitoring (IPM) or volumetric non-continuous pressure monitoring (VNPM).
It helps to diagnose heart failure, kidney problems, and other conditions. In addition, it can be used for measuring the effectiveness of drugs & therapies during treatment phase.
Application Insights:
The market is segmented by application into hospitals, clinics and other medical facilities, home care and ambulatory care. The hospital segment dominated the global non-invasive hemodynamic monitor market in 2017 due to a high prevalence of cardiovascular diseases that require invasive or semi-invasive procedures for measuring blood flow through the heart. According to data published by WHO in 2016, out of 17 million premature deaths globally every year, about 60% occur due to Cardiovascular Diseases (CVDs). Thus there is a significant demand for non-invasive monitors that are used as an alternative for these procedures at hospitals.
Clinical applications include use of invasive or semi-invasive devices such as catheters and wires that are used for measuring blood flow through arteries or veins depending upon their location within the human body. These devices have been found helpful not only during diagnostic but also during therapeutic procedures thus increasing its adoption rate across clinical settings including cardiology departments at hospitals around the world.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, high adoption rate of advanced technologies, and favorable reimbursement policies. The U.S., which is at the forefront of this region, has a well-developed healthcare infrastructure and highly developed research & development (R&D) activities that have resulted in technological advancements across all medical devices over time.
Asia Pacific is expected to witness lucrative growth during the forecast period owing to improving healthcare facilities and growing target population base with rising disposable income levels resulting in improved lifestyle habits such as smoking cessation, alcohol consumption reduction among others contributing toward higher disease prevalence rates including cardiac disorders such as hypertension or cardiac failure among others leading toward increased demand for these monitors over time. Moreover, increasing government initiatives for quality improvement are also anticipated favorably impact industry growth during the forecast period (2018 - 2030).
Growth Factors:
- Increasing prevalence of cardiovascular diseases (CVDs) and other chronic diseases
- Growing geriatric population
- Rising demand for home healthcare services
- Technological advancements in hemodynamic monitoring devices
- Government initiatives to promote use of non-invasive hemodynamic monitors
Scope Of The Report
Report Attributes
Report Details
Report Title
Non-invasive Hemodynamic Monitor Market Research Report
By Type
Continuously, Non-continuous
By Application
Hospitals, Cath Labs, Home and Ambulatory care
By Companies
Cheetah Medical, Inc., Sonosite Inc., CAS Medical Systems, Inc, DELTEX Medical Sciences, Inc., Edwards Lifesciences, HEMO Sapiens Inc, LIDCO Group PLC, Noninvasive Medical Technologies, Inc, GETINGE Group, Philips Healthcare, TENSYS Medical, Inc, DRAEGER, SCHWARZER CARDIOTEK GmBH, Vasamed, GE Healthcare Ltd
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
237
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Non-invasive Hemodynamic Monitor Market Report Segments:
The global Non-invasive Hemodynamic Monitor market is segmented on the basis of:
Types
Continuously, Non-continuous
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Cath Labs, Home and Ambulatory care
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Cheetah Medical, Inc.
- Sonosite Inc.
- CAS Medical Systems, Inc
- DELTEX Medical Sciences, Inc.
- Edwards Lifesciences
- HEMO Sapiens Inc
- LIDCO Group PLC
- Noninvasive Medical Technologies, Inc
- GETINGE Group
- Philips Healthcare
- TENSYS Medical, Inc
- DRAEGER
- SCHWARZER CARDIOTEK GmBH
- Vasamed
- GE Healthcare Ltd
Highlights of The Non-invasive Hemodynamic Monitor Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Continuously
- Non-continuous
- By Application:
- Hospitals
- Cath Labs
- Home and Ambulatory care
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Non-invasive Hemodynamic Monitor Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A non-invasive hemodynamic monitor is a device that measures blood pressure, heart rate, and oxygen levels. These monitors are often worn on the wrist or ankle and can be used to diagnose conditions such as hypertension or cardiac arrhythmia.
Some of the major players in the non-invasive hemodynamic monitor market are Cheetah Medical, Inc., Sonosite Inc., CAS Medical Systems, Inc, DELTEX Medical Sciences, Inc., Edwards Lifesciences, HEMO Sapiens Inc, LIDCO Group PLC, Noninvasive Medical Technologies, Inc, GETINGE Group, Philips Healthcare, TENSYS Medical, Inc, DRAEGER, SCHWARZER CARDIOTEK GmBH, Vasamed, GE Healthcare Ltd.
The non-invasive hemodynamic monitor market is expected to grow at a compound annual growth rate of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Non-invasive Hemodynamic Monitor Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Non-invasive Hemodynamic Monitor Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Non-invasive Hemodynamic Monitor Market - Supply Chain
4.5. Global Non-invasive Hemodynamic Monitor Market Forecast
4.5.1. Non-invasive Hemodynamic Monitor Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Non-invasive Hemodynamic Monitor Market Size (000 Units) and Y-o-Y Growth
4.5.3. Non-invasive Hemodynamic Monitor Market Absolute $ Opportunity
5. Global Non-invasive Hemodynamic Monitor Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Non-invasive Hemodynamic Monitor Market Size and Volume Forecast by Type
5.3.1. Continuously
5.3.2. Non-continuous
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Non-invasive Hemodynamic Monitor Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Non-invasive Hemodynamic Monitor Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Cath Labs
6.3.3. Home and Ambulatory care
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Non-invasive Hemodynamic Monitor Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Non-invasive Hemodynamic Monitor Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Non-invasive Hemodynamic Monitor Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Non-invasive Hemodynamic Monitor Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Non-invasive Hemodynamic Monitor Demand Share Forecast, 2019-2026
9. North America Non-invasive Hemodynamic Monitor Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Non-invasive Hemodynamic Monitor Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Non-invasive Hemodynamic Monitor Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Cath Labs
9.4.3. Home and Ambulatory care
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Non-invasive Hemodynamic Monitor Market Size and Volume Forecast by Type
9.7.1. Continuously
9.7.2. Non-continuous
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Non-invasive Hemodynamic Monitor Demand Share Forecast, 2019-2026
10. Latin America Non-invasive Hemodynamic Monitor Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Non-invasive Hemodynamic Monitor Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Non-invasive Hemodynamic Monitor Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Cath Labs
10.4.3. Home and Ambulatory care
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Non-invasive Hemodynamic Monitor Market Size and Volume Forecast by Type
10.7.1. Continuously
10.7.2. Non-continuous
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Non-invasive Hemodynamic Monitor Demand Share Forecast, 2019-2026
11. Europe Non-invasive Hemodynamic Monitor Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Non-invasive Hemodynamic Monitor Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Non-invasive Hemodynamic Monitor Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Cath Labs
11.4.3. Home and Ambulatory care
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Non-invasive Hemodynamic Monitor Market Size and Volume Forecast by Type
11.7.1. Continuously
11.7.2. Non-continuous
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Non-invasive Hemodynamic Monitor Demand Share, 2019-2026
12. Asia Pacific Non-invasive Hemodynamic Monitor Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Non-invasive Hemodynamic Monitor Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Non-invasive Hemodynamic Monitor Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Cath Labs
12.4.3. Home and Ambulatory care
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Non-invasive Hemodynamic Monitor Market Size and Volume Forecast by Type
12.7.1. Continuously
12.7.2. Non-continuous
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Non-invasive Hemodynamic Monitor Demand Share, 2019-2026
13. Middle East & Africa Non-invasive Hemodynamic Monitor Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Non-invasive Hemodynamic Monitor Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Non-invasive Hemodynamic Monitor Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Cath Labs
13.4.3. Home and Ambulatory care
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Non-invasive Hemodynamic Monitor Market Size and Volume Forecast by Type
13.7.1. Continuously
13.7.2. Non-continuous
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Non-invasive Hemodynamic Monitor Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Non-invasive Hemodynamic Monitor Market: Market Share Analysis
14.2. Non-invasive Hemodynamic Monitor Distributors and Customers
14.3. Non-invasive Hemodynamic Monitor Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Cheetah Medical, Inc.
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Sonosite Inc.
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. CAS Medical Systems, Inc
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. DELTEX Medical Sciences, Inc.
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Edwards Lifesciences
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. HEMO Sapiens Inc
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. LIDCO Group PLC
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Noninvasive Medical Technologies, Inc
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. GETINGE Group
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Philips Healthcare
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. TENSYS Medical, Inc
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. DRAEGER
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. SCHWARZER CARDIOTEK GmBH
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Vasamed
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. GE Healthcare Ltd
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
